Illumina Inc
(XSWX:ILMN)
CHF
143.95
-1.15 (-0.79%)
Market Cap: 21.66 Bil
Enterprise Value: 22.78 Bil
PE Ratio: 32.10
PB Ratio: 10.03
GF Score: 76/100 Illumina Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023 / 04:55PM GMT
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
All right. Hey, everyone. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. It's my pleasure to host Illumina today. And from the company, we have Joydeep Goswami, CFO; and Salli Schwartz, Head of Investor Relations. Welcome, guys.
Joydeep Goswami
Illumina, Inc. - CFO, Chief Strategy & Corporate Development Officer
Thank you.
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.
Questions & Answers
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
So maybe to kick things off, Joydeep, big news last week with Jacob Thaysen's appointment as CEO. This pick seems to signal a fresh start for Illumina with a renewed
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot